Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

I wanted to build an entire production‑ready business application by directing an AI inside a vibe coding environment without writing a single line of code myself.

A lot of making goes on in this community these days, but sometimes you’ve just gotta do some old fashioned hacking. You might have grabbed an old Speak and Spell that you want to repurpose ...